[go: up one dir, main page]

NO20053089L - Carbamic acid esters with anticolinergic action. - Google Patents

Carbamic acid esters with anticolinergic action.

Info

Publication number
NO20053089L
NO20053089L NO20053089A NO20053089A NO20053089L NO 20053089 L NO20053089 L NO 20053089L NO 20053089 A NO20053089 A NO 20053089A NO 20053089 A NO20053089 A NO 20053089A NO 20053089 L NO20053089 L NO 20053089L
Authority
NO
Norway
Prior art keywords
carbamic acid
acid esters
action
anticolinergic
relates
Prior art date
Application number
NO20053089A
Other languages
Norwegian (no)
Other versions
NO20053089D0 (en
Inventor
Georg Speck
Michael P Pieper
Matthias Hoffmann
Matthias Grauert
Steffen Breitfelder
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20053089D0 publication Critical patent/NO20053089D0/en
Publication of NO20053089L publication Critical patent/NO20053089L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to novel carbamic acid esters of general formula (1), in which X<-> and the groups A, R<1>, R<2>, R<3> and R<4> can be defined as cited in the claims and the description. The invention also relates to a method for producing said esters and to their use as medicaments, in particular medicaments with an anticholinergic action.
NO20053089A 2002-11-26 2005-06-23 Carbamic acid esters with anticolinergic action. NO20053089L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255040A DE10255040A1 (en) 2002-11-26 2002-11-26 New carbamic acid esters with anticholinergic activity
PCT/EP2003/012912 WO2004048373A1 (en) 2002-11-26 2003-11-19 Carbamic acid esters with an anticholinergic action

Publications (2)

Publication Number Publication Date
NO20053089D0 NO20053089D0 (en) 2005-06-23
NO20053089L true NO20053089L (en) 2005-06-23

Family

ID=32240420

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053089A NO20053089L (en) 2002-11-26 2005-06-23 Carbamic acid esters with anticolinergic action.

Country Status (20)

Country Link
EP (1) EP1567526B1 (en)
JP (1) JP4754829B2 (en)
KR (1) KR20050086821A (en)
CN (1) CN1717408A (en)
AT (1) ATE392424T1 (en)
AU (1) AU2003289880A1 (en)
BR (1) BR0316549A (en)
CA (1) CA2507110C (en)
DE (2) DE10255040A1 (en)
EA (1) EA200500775A1 (en)
EC (1) ECSP055803A (en)
ES (1) ES2304538T3 (en)
HR (1) HRP20050465A2 (en)
MX (1) MXPA05005443A (en)
NO (1) NO20053089L (en)
PL (1) PL376638A1 (en)
RS (1) RS20050384A (en)
UA (1) UA81649C2 (en)
WO (1) WO2004048373A1 (en)
ZA (1) ZA200502946B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE435862T1 (en) 2003-05-28 2009-07-15 Theravance Inc AZABICYCLOALKAN COMPOUNDS AS MUSCARINE RECEPTOR ANTAGONISTS
TW200534855A (en) * 2004-01-13 2005-11-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
JP2008505118A (en) * 2004-06-30 2008-02-21 グラクソ　グループ　リミテッド Muscarinic acetylcholine receptor antagonist
JP2008520573A (en) * 2004-11-15 2008-06-19 グラクソ グループ リミテッド Novel M3 muscarinic acetylcholine receptor antagonist
WO2007007282A2 (en) * 2005-07-11 2007-01-18 Ranbaxy Laboratories Limited Azabicyclo derivatives as muscarinic receptor antagonists
US20090182033A1 (en) * 2005-12-16 2009-07-16 Argenta Discovery Ltd. Cyclic Amine Derivatives and Their Uses
US8367696B2 (en) 2007-02-09 2013-02-05 Astellas Pharma Inc. Aza-bridged-ring compound
PT3691620T (en) 2017-10-05 2022-10-06 Fulcrum Therapeutics Inc P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019096226A1 (en) 2017-11-16 2019-05-23 Chengdu Easton Biopharmaceuticals Co., Ltd. Pasylated vegfr/pdgfr fusion proteins and their use in therapy
JP2021505569A (en) * 2017-12-04 2021-02-18 フリードリヒ−アレクサンダー−ウニヴェルシテート エアランゲン−ニュルンベルク Fluorophenyl-substituted muscarinic receptor ligand that is more selective for M3 than M2
KR20220001259A (en) 2020-06-29 2022-01-05 (주)아모레퍼시픽 Surface-treated inorganic particles, manufacturing method of the same, dispersion solution of the same and cosmetic composition comprising the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759460A (en) * 1969-11-26 1971-05-26 Knoll Ag NEW CARBAMATES AND THEIR PREPARATION PROCESS
GB8600978D0 (en) * 1986-01-16 1986-02-19 Beecham Group Plc Compounds
IT1228293B (en) * 1989-02-06 1991-06-07 Angeli Inst Spa BENZODERIVATES OF HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN.
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
AU7545894A (en) * 1993-09-02 1995-03-22 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
EP0747355A4 (en) * 1994-02-10 1997-04-09 Yamanouchi Pharma Co Ltd Novel carbamate derivative and medicinal composition containing the same
AU724780B2 (en) * 1996-03-20 2000-09-28 Wake Forest University Sigma-2 receptors as biomarkers of tumor cell proliferation

Also Published As

Publication number Publication date
JP2006514010A (en) 2006-04-27
CA2507110C (en) 2012-07-10
DE50309655D1 (en) 2008-05-29
BR0316549A (en) 2005-10-04
JP4754829B2 (en) 2011-08-24
PL376638A1 (en) 2006-01-09
DE10255040A1 (en) 2004-06-03
ES2304538T3 (en) 2008-10-16
ECSP055803A (en) 2005-08-11
NO20053089D0 (en) 2005-06-23
CN1717408A (en) 2006-01-04
HRP20050465A2 (en) 2006-10-31
KR20050086821A (en) 2005-08-30
AU2003289880A1 (en) 2004-06-18
EA200500775A1 (en) 2005-12-29
RS20050384A (en) 2007-12-31
CA2507110A1 (en) 2004-06-10
WO2004048373A1 (en) 2004-06-10
EP1567526B1 (en) 2008-04-16
UA81649C2 (en) 2008-01-25
EP1567526A1 (en) 2005-08-31
MXPA05005443A (en) 2005-08-03
ZA200502946B (en) 2005-11-23
ATE392424T1 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
MY134582A (en) New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments
DK1613304T3 (en) DPP-IV inhibitors
EA200400368A1 (en) NEW DIHYDROPTERIDINONES, METHODS FOR THEIR PRODUCTION AND THEIR USE AS MEDICINES
NL300933I2 (en) Letermovir
ATE259779T1 (en) FORMOTEROL POLYMORPHOS
BR0316375A (en) Diazinopyrimidines
SE0301882D0 (en) New use I
SE0301886D0 (en) New use V
ATE542803T1 (en) METHOD FOR PRODUCING DIHYDROQUINAZOLINES
BR0306922A (en) N-pyrazinyl phenylsulfonamides and their use in the treatment of chemokine mediated diseases
NO20053089D0 (en) Carbamic acid esters with anticolinergic action.
SE0302324D0 (en) Novel compounds
ATE335738T1 (en) XANTHENE CARBONIC ACID ESTERS OF TROPENOL AND SCOPINE AS M3 ANTAGONISTS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
SE0302323D0 (en) Novel compounds
MXPA03009548A (en) Arylsulfonamides as antiviral agents.
ATE394379T1 (en) 4-ALKOXY-CYCLOHEXANE-1-AMINO-CARBONIC ACID ESTERS AND METHOD FOR THE PRODUCTION THEREOF
CA2421990A1 (en) .beta.-thioamino acids
DE502004003952D1 (en) ENZYMATIC PREPARATION OF (METH) ACRYLIC ACID ESTERS
DE50312796D1 (en) PROCESS FOR THE PREPARATION OF ISOCYANATES
EA200300272A1 (en) NEW HINAZOLIN DERIVATIVES, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO2008023003A8 (en) Drug combinations for treating airway diseases
MXPA02001406A (en) Substituted heterocyclyl-2h-chromenes.
ATE392413T1 (en) METHOD FOR PRODUCING BETA-ALANINAMIDES
SE0201938D0 (en) New process
MX2007005874A (en) N-heterocyclyl phthalic acid diamides as insecticides.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application